title: [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
authors.forename: Oriol
authors.initials: O
authors.lastname: Gasch
authors.forename: Nuria
authors.initials: N
authors.lastname: Fernández
authors.forename: Josefina
authors.initials: J
authors.lastname: Ayats
authors.forename: Miguel
authors.initials: M
authors.lastname: Santin
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy*; D001232:Aspergillus fumigatus / Q000302:isolation & purification; D001922:Brain Abscess / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D000077336:Caspofungin; D003840:Deoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D054714:Echinocandins / Q000008:administration & dosage / Q000627:therapeutic use*; D017809:Fatal Outcome; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000150:complications / Q000382:microbiology; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D004338:Drug Combinations; D054714:Echinocandins; D055666:Lipopeptides; D011743:Pyrimidines; D014230:Triazoles; D003840:Deoxycholic Acid; D000666:Amphotericin B; C059765:amphotericin B, deoxycholate drug combination; D000077336:Caspofungin; D065819:Voriconazole